Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

132 results about "Treatment duration" patented technology

Practically, duration of treatment ranges from 3 months to lifelong. Deciding how long a patient with a venous thromboembolic event should be treated for is important. Recurrence risk may be as high as 50% for unprovoked events after 10 years.

Non-invasive skin treatment device using r.f. electrical current with a treatment settings determiner

The invention provides a non-invasive skin treatment device (100) comprising an r.f. treatment electrode (10); a return electrode (40); an r.f. generator (20) configured and arranged such that, during treatment, an r.f. treatment signal is applied between the r.f. treatment electrode (10) and the return electrode (40) for heating an inner region (15) of skin; an impedance measurement circuit (35) configured and arranged to measure, before treatment of the inner region, an initial skin impedance (Zo) between the r.f. treatment electrode (10) and the return electrode (40); and a treatment settings determiner (30) configured and arranged to determine, before treatment of the inner region (15), treatment settings associated with the r.f. treatment signal depending on the initial skin impedance (Zo) and on a dimension of the r.f. treatment electrode (10) in the contact plane, the treatment settings comprising at least one of a treatment duration (TD) associated with a desired treatment result, and an r.f. electrical parameter associated with the r.f. treatment signal. The skin treatment device (100) further comprises a controller (25) configured and arranged to consecutively activate the impedance measurement circuit (35) and the treatment settings determiner (30) before treatment of the inner region (15), configure the r.f. generator (20) to provide the r.f. treatment signal according to the treatment settings, and activate the r.f. generator (20) to apply the r.f. treatment signal to the inner region (15) for the treatment duration (TD). The invention is based on the insight obtained from multiple measurements made during the creation of microscopic thermal lesions in an inner region of skin by applying r.f. measurement and treatment signals. By analyzing the histological and heating results, a relationship was obtained between the initial impedance (Zo), the dimension of the r.f. treatment electrode (10), and the treatment settings required to obtain a particular skin treatment result. This relationship has been found to be relatively constant for different subjects, different treatment locations on the body and different skin moisture contents. The invention makes it possible to preset or predetermine, i.e. in advance, the treatment duration (TD) and/or the r.f. electrical parameters associated with the r.f. treatment signal accurately enough to avoid undesired skin damage during the treatment. The device can be simpler, as it is no longer essential to continuously monitor the impedance during treatment to determine the onset of undesired skin damage, such as ablation, which is the safety feature known from conventional devices.
Owner:KONINKLJIJKE PHILIPS NV

Radio-frequency electrode treatment catheter and radio-frequency electrode treatment device

InactiveCN105832409AAvoid Conductive SituationsIncreased treatment lengthSurgical instruments for heatingVascular diseaseTreatment duration
The invention provides a radio-frequency electrode treatment catheter and a radio-frequency electrode treatment device. The radio-frequency electrode treatment catheter comprises a catheter and at least one group of radio-frequency electrodes, wherein one or more groups of radio-frequency electrodes are arranged on the catheter, each group of radio-frequency electrodes comprises a plurality of first radio-frequency electrode units and second radio-frequency electrode units corresponding to each other, each of the first radio-frequency electrode units and the second radio-frequency electrode units is alternately arranged on the surface of the catheter at intervals along at least one direction, and radio-frequency power supplies applied by the first radio-frequency electrode units and the second radio-frequency electrode units are opposite in polarity. The treatment catheter for treating vascular diseases is improved, the electric conduction situation between different radio-frequency electrodes is avoided, a better curative effect can be achieved in the vascular disease treatment process, the treatment duration is prolonged by virtue of ingenious interval, and then the convenience in treatment is improved.
Owner:SHENZHEN PENINSULA MEDICAL CO LTD

Method for cleaning injectors of a direct-injection controlled-ignition engine

ActiveCN107810320AStable temperatureGuaranteed non-"hazardous" working conditionsElectrical controlEngine testingTreatment durationMaximum pressure
The invention relates to a method for cleaning injectors of a direct-injection controlled-ignition engine, whereby, when the said engine is operating at no load, the maximum fuel pressure at the injector is calculated first of all with a view to cleaning, by executing, for at least one predetermined engine operating speed, an iterative loop during each iteration of which the value of the pressureof the injected fuel is incremented by a predetermined value and the corresponding injection time at the said incremented pressure is determined so as to select, for each operating speed, a cleaning pressure equal either to the maximum fuel pressure that corresponds to an injection time longer than the calibrated minimum injection time determined for the said operating speed, or to a ceiling maximum pressure corresponding to a determined calibrated pressure for the engine / injectors system, if this calibrated pressure is reached while the iterative loop is being executed. Next, a cleaning treatment is applied that consists in selecting an operating speed that allows the maximum cleaning pressure, and in commanding the engine to operate with this speed applied and by programming the said cleaning pressure, for a treatment duration greater than the operating time permitted during running under such operating conditions.
Owner:VTESCO TECH GMBH

Human colorectal cancer cetuximab drug-resistant cell line and application thereof

The invention discloses a human colorectal cancer cetuximab drug-resistant cell line, and belongs to the field of biomedical technology. The human colorectal cancer cetuximab drug-resistant cell linehas the advantages that a human colorectal cancer cell line NCI-H508 is treated by the cetuximab of different concentration, and the drug concentration for survival of 50% of cells is used as the initial concentration to treat the cells for a long time, until the cell NCI-H508 can normally grow under the concentration; the cell NCI-H508 is continued to treat for a long time by a gradual increasingmethod, the treatment duration is six months, and finally the human colorectal cancer cetuximab drug-resistant cell line NCI-H508 / C225 which can quickly grow under the treatment function of the cetuximab can be finally obtained; the human colorectal cancer cetuximab drug-resistant cell line can be used for analyzing the phenotypic change of morphology and biology after drug resistance of human colorectal cancer cetuximab, studying the molecule mechanism of the human colorectal cancer cetuximab drug resistance and the reversing drug resistance method, screening other anti-tumor drugs, findingthe tumor drug-resistant markers, and screening and evaluating the novel antitumor drugs and the like, and the scientific and research value and the production and application value are higher.
Owner:JIANGSU CANCER HOSPITAL

Thrombolysis device promoting absorption of medicine by using ultrasonic waves

The invention discloses a thrombolysis device promoting absorption of medicine by using ultrasonic waves, and belongs to the technical field of medical instruments. The thrombolysis device promoting absorption of medicine by using ultrasonic waves comprises an operating handle, a medicine release catheter and an ultrasonic guide wire, wherein the operating handle is fixedly connected with the medicine release catheter through a Ruhr joint; and the operating handle consists of a casing, an ultrasonic generator, an ultrasonic transducer, a battery, an ultrasonic switch and an ultrasonic adjusting knob. The thrombolysis device promoting absorption of medicine by using ultrasonic waves performs continuous ultrasonic cavitation treatment on the thrombolysis medicine at a thrombus part, and greatly promotes penetration and dissolution of thrombus by the thrombolysis medicine; the ultrasonic guide wire is located in a medicine release catheter, and does not make contact with blood vessel walls or damage blood vessel walls and surrounding tissue. When used for clearing thrombus, the thrombolysis device promoting absorption of medicine by using ultrasonic waves has the advantages of good thrombolysis effects, short treatment time, simple operation, safety, reliability and the like.
Owner:江苏金泰医疗器械有限公司

Chinese medicine for treating lumbar disc herniation and hyperosteogeny and use method of Chinese medicine

ActiveCN103055295AForce importFix stab damageSkeletal disorderSheet deliveryDiseaseTreatment effect
The invention relates to a Chinese medicine, and in particular relates to a Chinese medicine for treating lumbar disc herniation and hyperosteogeny and a use method of the Chinese medicine. The Chinese medicine is composed of rhizoma zingiberis, rhizoma typhonii, job's tears, codonopsis pilosula, radix aucklandiae, lovage, divaricate saposhnikovia root, cynanchum paniculatum, eucommia ulmoides oliv, radix morindae officinalis, fructus psoraleae, safflower, angelica, rhizoma curculiginis and epimedium herb. The raw materials are immersed with rice wine for 10-20 days. The Chinese medicine for treating lumbar disc herniation and hyperosteogeny disclosed by the invention has the advantages that treatment effect is quick, treatment and use are convenient, the Chinese medicine is safe in treatment duration, a patient does not need to hardly take medicine, and the Chinese medicine can be prevented from being rejected by other medicines during treatment. By treating lumbar disc herniation and hyperosteogeny with the medicine and corresponding usage, the curing time is shorted by half than that of internal treatment and good effect is immediately taken when attacking. The disease development of the patients who need surgeries because of lumbar disc herniation is greatly slowed by using the therapy for 3-5 days, the pain is practically disappeared for 10 days, the pain condition of nerve drawing of the patients is diminished for 20 days, and the patients are basically recovered for 30 days. Thus, the recovery rate reaches more than 95%.
Owner:邱垂宁
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products